An issue I am considering to write my final case study on is about Apple CEO Steve Jobs and shareholder reaction to his sickly appearance. Apple released news of Jobs' pancreatic cancer when he had his surgery to remove it. Since then it has been a situation closely monitored by investors. Essentially many believe that Jobs is the driving creative force of the organization and thus heavily weight his health on the success of the company.
Although there are no legal requirements to submit updates on the health of the company's employees, shareholders still should probably be informed on the health of upper-management. If handled correctly, shareholders can generate more trust in the IRO's, but moving forward if Apple denies serious health questions for being only small issues of concern and it turns out Jobs is not doing very well, then it could result in a serious dip in share price.
No comments:
Post a Comment